ישראל - עברית - Ministry of Health

abic marketing ltd, israel - doxorubicin hydrochloride - תרכיז להכנת תמיסה לאינפוזיה - doxorubicin hydrochloride 2 mg/ml - doxorubicin - doxorubicin - to produce regression in disseminated neoplastic conditions such as: - acute lymphoblastic leukemia, - acute myeloblastic leukemia, - wilms' tumor neuroblastoma, - soft tissue and bone sarcomas, - breast carcinoma, - lymphomas of both hodgkin's and non-hodgkin's types, - bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types, - gastric carcinoma.

ישראל - עברית - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - liposome for infusion - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin - doxorubicin - first or second line therapy of aids related kaposis sarcoma in patients with low cd 4 counts and extensive mucocutaneous or visceral disease the treatment of patients with metastatic carcinoma of the ovary who are refractory to both paclitaxel and platinium-based chemotherapy regimens and who may also be refractory to topotecan. refractory is defined as a patient having progressive disease while on treatment or within 6 months of completing treatmnt. as monotherapy for patients with metastatic breast cancer where there is an increased cardiac risk. in combination with bortezomib for the treatment of progressive multiplemyeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant.

ישראל - עברית - Ministry of Health

novartis israel ltd - doxorubicin hydrochloride - solution for infusion - doxorubicin hydrochloride 2 mg/ml - doxorubicin - doxorubicin - soft tissue and bone sarcomas, hodgkin's and non-hodgkin's lymphoma, acute lymphoblastic leukemia, acute myeloblastic leukemia, wilms` tumor, carcinomas of the thyroid, breast, ovary, bladder, small cell bronchogenic carcinoma and neuroblastoma.

ישראל - עברית - Ministry of Health

medison pharma ltd - doxorubicin hydrochloride - אבקה, מפזר וממס להכנת תרכיז לפיזור באינפוזיה - doxorubicin hydrochloride 50 mg vials - doxorubicin - doxorubicin - myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women.

ישראל - עברית - Ministry of Health

taro international ltd, israel - doxorubicin hydrochloride - doxorubicin hydrochloride 2 mg / 1 ml - doxorubicin

ישראל - עברית - Ministry of Health

j-c health care ltd - doxorubicin hydrochloride - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin

ישראל - עברית - Ministry of Health

baxter healthcare distribution ltd., israel - doxorubicin hydrochloride - doxorubicin hydrochloride 2.0 mg/ml - doxorubicin

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 10 mg / 5 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - doxorubicin hydrochloride 50 mg / 25 ml - solution for injection - doxorubicin - adriblastina has been used successfully to produce regression in a variety of neoplastic conditions, such as carcinoma of the breast, lung, bladder, thyroid, and also ovarian carcinomas, bone and soft-tissue sarcomas, hodgkin's and non- hodgkin's lymphomas, neuroblastomas, wilms tumour, acute lymphoblastic leukaemia and acute myeloblastic leukaemia

ישראל - עברית - Ministry of Health

novartis israel ltd - docetaxel - תרכיז להכנת תמיסה לאינפוזיה - docetaxel 10 mg / 1 ml - docetaxel - docetaxel - breast cancer: docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. docetaxel in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. docetaxel monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. docetaxel in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracyclin